AUTL
Autolus Therapeutics
AUTL
AUTL
48 hedge funds and large institutions have $113M invested in Autolus Therapeutics in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
21% less capital invested
Capital invested by funds: $142M → $113M (-$29M)
Holders
48
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.87M | |
| 2 | +$1.39M | |
| 3 | +$957K | |
| 4 |
Morgan Stanley
New York
|
+$836K |
| 5 |
JP Morgan Chase
New York
|
+$676K |
Top Sellers
| 1 | -$3.32M | |
| 2 | -$1.14M | |
| 3 | -$1.05M | |
| 4 |
Two Sigma Investments
New York
|
-$386K |
| 5 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$285K |